Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Wrangle, John
One or more keywords matched the following properties of Wrangle, John
PropertyValue
keywords Cancer/Lung
One or more keywords matched the following items that are connected to Wrangle, John
Item TypeName
Concept Lung Neoplasms
Academic Article Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer.
Academic Article Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer.
Academic Article Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events.
Academic Article Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.
Academic Article Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer.
Academic Article Prospective CT screening for lung cancer in a high-risk population: HIV-positive smokers.
Academic Article Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.
Academic Article Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer.
Academic Article Imaging in Advanced Non-Small Cell Lung Cancer: A Medical Oncology Perspective.
Academic Article Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum.
Academic Article First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
Academic Article ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial.
Academic Article Can We MIRror the Efficacy of Immune Checkpoints With miRNAs?
Academic Article A Phase 1-2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC.
Search Criteria
  • Lung Neoplasms